11-34112168-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_024662.3(NAT10):āc.317A>Gā(p.Tyr106Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,892 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_024662.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NAT10 | NM_024662.3 | c.317A>G | p.Tyr106Cys | missense_variant | 4/29 | ENST00000257829.8 | NP_078938.3 | |
NAT10 | NM_001144030.2 | c.101A>G | p.Tyr34Cys | missense_variant | 2/27 | NP_001137502.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NAT10 | ENST00000257829.8 | c.317A>G | p.Tyr106Cys | missense_variant | 4/29 | 1 | NM_024662.3 | ENSP00000257829 | P1 | |
NAT10 | ENST00000531159.6 | c.101A>G | p.Tyr34Cys | missense_variant | 2/27 | 2 | ENSP00000433011 | |||
NAT10 | ENST00000527971.5 | c.317A>G | p.Tyr106Cys | missense_variant | 3/8 | 2 | ENSP00000437324 | |||
NAT10 | ENST00000529523.5 | c.317A>G | p.Tyr106Cys | missense_variant | 4/5 | 4 | ENSP00000435569 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727248
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The c.317A>G (p.Y106C) alteration is located in exon 4 (coding exon 3) of the NAT10 gene. This alteration results from a A to G substitution at nucleotide position 317, causing the tyrosine (Y) at amino acid position 106 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.